APO RESEARCH · REPORT
Infusion Pharmacy Management
Infusion therapy is prescribed to patient only when patient condition is severe or oral medication are less effective. Infusion Pharmacy includes infusion of antibiotic, antifungal, antiviral, pain management and nutritional drug through needle or catheter. Diseases such as cancer, diabetes, gastrointestinal disorder and pain related disorders are generally treated with infusion medication system. Infusion pharmacy can also be administered in home by providing doorstep services. Home infusion pharmacy management is more costly than hospital infusion pharmacy management because it requires more skilled nursing facilities. This report studies the Infusion Pharmacy Management market.
Product & engineering
Understand the product.
Infusion therapy is prescribed to patient only when patient condition is severe or oral medication are less effective. Infusion Pharmacy includes infusion of antibiotic, antifungal, antiviral, pain management and nutritional drug through needle or catheter. Diseases such as cancer, diabetes, gastrointestinal disorder and pain related disorders are generally treated with infusion medication system. Infusion pharmacy can also be administered in home by providing doorstep services. Home infusion pharmacy management is more costly than hospital infusion pharmacy management because it requires more skilled nursing facilities. This report studies the Infusion Pharmacy Management market.
Selected research
Industry Research
Infusion Pharmacy Management Industry Research Report 2026
Market perspective
Infusion therapy is prescribed to patient only when patient condition is severe or oral medication are less effective. Infusion Pharmacy includes infusion of antibiotic, antifungal, antiviral, pain management and nutritional drug through needle or catheter. Diseases such as cancer, diabetes, gastrointestinal disorder and pain related disorders are generally treated with infusion medication system. Infusion pharmacy can also be administered in home by providing doorstep services. Home infusion pharmacy management is more costly than hospital infusion pharmacy management because it requires more skilled nursing facilities. This report studies the Infusion Pharmacy Management market.
In United States market, Infusion Pharmacy Management key players include BioScrip, BD, Cigna, Option Care, CVS Health, etc. The top five manufacturers hold a share about 70%. South is the largest market, with a share about 35%, followed by Midwest, with a share about 20 percent. In terms of product, Antimicrobial is the largest segment, with a share about 20%. And in terms of application, the largest application is Home Care, followed by Hospital & Clinic, Ambulatory Surgical Centers, etc.
Report Scope
Read the full market overview
This report quantifies the global Infusion Pharmacy Management market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Infusion Pharmacy Management.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Infusion Pharmacy Management Market by Company
BioScrip
BD
Cigna
Option Care
CVS Health
McKesson
Mediware
OptumRx
Healix
CareCentrix
MedicoRx
Ivenix
ARJ Infusion Services
Brightree
Accredo Health
MHA
ContinuumRx
Infusion Pharmacy Management Segment by Type
Antibiotics
Antimicrobial
Pain Management
Enteral Nutrition
Others
Infusion Pharmacy Management Segment by Application
Hospital & Clinic
Ambulatory Surgical Centers
Home Care
Infusion Pharmacy Management Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infusion Pharmacy Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Infusion Pharmacy Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infusion Pharmacy Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Infusion Pharmacy Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Antibiotics
- Antimicrobial
- Pain Management
- Enteral Nutrition
- Others
Applications
- Hospital & Clinic
- Ambulatory Surgical Centers
- Home Care
Companies covered
- BioScrip
- BD
- Cigna
- Option Care
- CVS Health
- McKesson
- Mediware
- OptumRx
- Healix
- CareCentrix
- MedicoRx
- Ivenix
- ARJ Infusion Services
- Brightree
- Accredo Health
- MHA
- ContinuumRx
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Infusion Pharmacy Management by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Antibiotics
- 2.2.3 Antimicrobial
- 2.2.4 Pain Management
- 2.2.5 Enteral Nutrition
- 2.2.6 Others
- 2.3 Infusion Pharmacy Management by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital & Clinic
- 2.3.3 Ambulatory Surgical Centers
- 2.3.4 Home Care
- 2.4 Assumptions and Limitations
3 Infusion Pharmacy Management Breakdown Data by Type
- 3.1 Global Infusion Pharmacy Management Historic Market Size by Type (2021-2026)
- 3.2 Global Infusion Pharmacy Management Forecasted Market Size by Type (2027-2032)
4 Infusion Pharmacy Management Breakdown Data by Application
- 4.1 Global Infusion Pharmacy Management Historic Market Size by Application (2021-2026)
- 4.2 Global Infusion Pharmacy Management Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Infusion Pharmacy Management Market Perspective (2021-2032)
- 5.2 Global Infusion Pharmacy Management Growth Trends by Region
- 5.2.1 Global Infusion Pharmacy Management Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Infusion Pharmacy Management Historic Market Size by Region (2021-2026)
- 5.2.3 Infusion Pharmacy Management Forecasted Market Size by Region (2027-2032)
- 5.3 Infusion Pharmacy Management Market Dynamics
- 5.3.1 Infusion Pharmacy Management Industry Trends
- 5.3.2 Infusion Pharmacy Management Market Drivers
- 5.3.3 Infusion Pharmacy Management Market Challenges
- 5.3.4 Infusion Pharmacy Management Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Infusion Pharmacy Management Players by Revenue
- 6.1.1 Global Top Infusion Pharmacy Management Players by Revenue (2021-2026)
- 6.1.2 Global Infusion Pharmacy Management Revenue Market Share by Players (2021-2026)
- 6.2 Global Infusion Pharmacy Management Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Infusion Pharmacy Management Head Office and Area Served
- 6.4 Global Infusion Pharmacy Management Players, Product Type & Application
- 6.5 Global Infusion Pharmacy Management Manufacturers Established Date
- 6.6 Global Infusion Pharmacy Management Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Infusion Pharmacy Management Market Size (2021-2032)
- 7.2 North America Infusion Pharmacy Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Infusion Pharmacy Management Market Size by Country (2021-2026)
- 7.4 North America Infusion Pharmacy Management Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Infusion Pharmacy Management Market Size (2021-2032)
- 8.2 Europe Infusion Pharmacy Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Infusion Pharmacy Management Market Size by Country (2021-2026)
- 8.4 Europe Infusion Pharmacy Management Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Infusion Pharmacy Management Market Size (2021-2032)
- 9.2 Asia-Pacific Infusion Pharmacy Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Infusion Pharmacy Management Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Infusion Pharmacy Management Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Infusion Pharmacy Management Market Size (2021-2032)
- 10.2 South America Infusion Pharmacy Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Infusion Pharmacy Management Market Size by Country (2021-2026)
- 10.4 South America Infusion Pharmacy Management Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Infusion Pharmacy Management Market Size (2021-2032)
- 11.2 Middle East & Africa Infusion Pharmacy Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Infusion Pharmacy Management Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Infusion Pharmacy Management Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 BioScrip
- 12.1.1 BioScrip Company Information
- 12.1.2 BioScrip Business Overview
- 12.1.3 BioScrip Revenue in Infusion Pharmacy Management Business (2021-2026)
- 12.1.4 BioScrip Infusion Pharmacy Management Product Portfolio
- 12.1.5 BioScrip Recent Developments
- 12.2 BD
- 12.2.1 BD Company Information
- 12.2.2 BD Business Overview
- 12.2.3 BD Revenue in Infusion Pharmacy Management Business (2021-2026)
- 12.2.4 BD Infusion Pharmacy Management Product Portfolio
- 12.2.5 BD Recent Developments
- 12.3 Cigna
- 12.3.1 Cigna Company Information
- 12.3.2 Cigna Business Overview
- 12.3.3 Cigna Revenue in Infusion Pharmacy Management Business (2021-2026)
- 12.3.4 Cigna Infusion Pharmacy Management Product Portfolio
- 12.3.5 Cigna Recent Developments
- 12.4 Option Care
- 12.4.1 Option Care Company Information
- 12.4.2 Option Care Business Overview
- 12.4.3 Option Care Revenue in Infusion Pharmacy Management Business (2021-2026)
- 12.4.4 Option Care Infusion Pharmacy Management Product Portfolio
- 12.4.5 Option Care Recent Developments
- 12.5 CVS Health
- 12.5.1 CVS Health Company Information
- 12.5.2 CVS Health Business Overview
- 12.5.3 CVS Health Revenue in Infusion Pharmacy Management Business (2021-2026)
- 12.5.4 CVS Health Infusion Pharmacy Management Product Portfolio
- 12.5.5 CVS Health Recent Developments
- 12.6 McKesson
- 12.6.1 McKesson Company Information
- 12.6.2 McKesson Business Overview
- 12.6.3 McKesson Revenue in Infusion Pharmacy Management Business (2021-2026)
- 12.6.4 McKesson Infusion Pharmacy Management Product Portfolio
- 12.6.5 McKesson Recent Developments
- 12.7 Mediware
- 12.7.1 Mediware Company Information
- 12.7.2 Mediware Business Overview
- 12.7.3 Mediware Revenue in Infusion Pharmacy Management Business (2021-2026)
- 12.7.4 Mediware Infusion Pharmacy Management Product Portfolio
- 12.7.5 Mediware Recent Developments
- 12.8 OptumRx
- 12.8.1 OptumRx Company Information
- 12.8.2 OptumRx Business Overview
- 12.8.3 OptumRx Revenue in Infusion Pharmacy Management Business (2021-2026)
- 12.8.4 OptumRx Infusion Pharmacy Management Product Portfolio
- 12.8.5 OptumRx Recent Developments
- 12.9 Healix
- 12.9.1 Healix Company Information
- 12.9.2 Healix Business Overview
- 12.9.3 Healix Revenue in Infusion Pharmacy Management Business (2021-2026)
- 12.9.4 Healix Infusion Pharmacy Management Product Portfolio
- 12.9.5 Healix Recent Developments
- 12.10 CareCentrix
- 12.10.1 CareCentrix Company Information
- 12.10.2 CareCentrix Business Overview
- 12.10.3 CareCentrix Revenue in Infusion Pharmacy Management Business (2021-2026)
- 12.10.4 CareCentrix Infusion Pharmacy Management Product Portfolio
- 12.10.5 CareCentrix Recent Developments
- 12.11 MedicoRx
- 12.11.1 MedicoRx Company Information
- 12.11.2 MedicoRx Business Overview
- 12.11.3 MedicoRx Revenue in Infusion Pharmacy Management Business (2021-2026)
- 12.11.4 MedicoRx Infusion Pharmacy Management Product Portfolio
- 12.11.5 MedicoRx Recent Developments
- 12.12 Ivenix
- 12.12.1 Ivenix Company Information
- 12.12.2 Ivenix Business Overview
- 12.12.3 Ivenix Revenue in Infusion Pharmacy Management Business (2021-2026)
- 12.12.4 Ivenix Infusion Pharmacy Management Product Portfolio
- 12.12.5 Ivenix Recent Developments
- 12.13 ARJ Infusion Services
- 12.13.1 ARJ Infusion Services Company Information
- 12.13.2 ARJ Infusion Services Business Overview
- 12.13.3 ARJ Infusion Services Revenue in Infusion Pharmacy Management Business (2021-2026)
- 12.13.4 ARJ Infusion Services Infusion Pharmacy Management Product Portfolio
- 12.13.5 ARJ Infusion Services Recent Developments
- 12.14 Brightree
- 12.14.1 Brightree Company Information
- 12.14.2 Brightree Business Overview
- 12.14.3 Brightree Revenue in Infusion Pharmacy Management Business (2021-2026)
- 12.14.4 Brightree Infusion Pharmacy Management Product Portfolio
- 12.14.5 Brightree Recent Developments
- 12.15 Accredo Health
- 12.15.1 Accredo Health Company Information
- 12.15.2 Accredo Health Business Overview
- 12.15.3 Accredo Health Revenue in Infusion Pharmacy Management Business (2021-2026)
- 12.15.4 Accredo Health Infusion Pharmacy Management Product Portfolio
- 12.15.5 Accredo Health Recent Developments
- 12.16 MHA
- 12.16.1 MHA Company Information
- 12.16.2 MHA Business Overview
- 12.16.3 MHA Revenue in Infusion Pharmacy Management Business (2021-2026)
- 12.16.4 MHA Infusion Pharmacy Management Product Portfolio
- 12.16.5 MHA Recent Developments
- 12.17 ContinuumRx
- 12.17.1 ContinuumRx Company Information
- 12.17.2 ContinuumRx Business Overview
- 12.17.3 ContinuumRx Revenue in Infusion Pharmacy Management Business (2021-2026)
- 12.17.4 ContinuumRx Infusion Pharmacy Management Product Portfolio
- 12.17.5 ContinuumRx Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst